Our mission is to exploit the potential of marine bioactives for the treatment of human diseases.
KinSea Lead Discovery AS is dedicated to harnessing the vast potential of marine bioactives to develop innovative treatments for human diseases. Focused on pharmaceutical manufacturing, KinSea Lead Discovery AS is pioneering a drug discovery pipeline that bridges the gap between academia and industry to unlock the therapeutic possibilities of natural marine products from the Arctic Ocean.
Based in Tromsø, KinSea Lead Discovery AS is committed to developing targeted therapies for hematological malignancies and other diseases with significant unmet clinical needs. With a promising FLT3 inhibitor asset that has demonstrated successful animal proof-of-concept, KinSea Lead Discovery AS is poised to make significant advancements in the pharmaceutical landscape.
KinSea Lead Discovery AS operates primarily out of Tromsø, NO. We invite the management team at KinSea Lead Discovery AS to take advantage of our platform to create a customized company showcase and product listing, providing an exclusive and comprehensive view of your offerings to a wider audience.
Other organizations in the same industry
This company is also known as